Excedrin by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Drug facts, warnings, and ingredients follow.
Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.
Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
Allergy alert: Aspirin may cause a severe allergic reaction which may include:
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
Caffeine warning: The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heart beat.
These could be signs of a serious condition
NDC: 0067-2001-05
EXCEDRIN
EXTRA STRENGTH
Acetaminophen, Aspirin (NSAID) and Caffeine
Pain Reliever/Pain Reliever Aid
100 CAPLETS
TAMPER-EVIDENT BOTTLE
DO NOT USE IF INNER FOIL SEAL INPRINTED WITH “SEALED for YOUR PROTECTION” IS BROKEN OR MISSING
Distributed by: GSK Consumer Healthcare, Warren, NJ 07059
©2018 GSK group of companies or its licensor.
Trademarks are owned by or licensed to the GSK group of companies.
62000000032208
EXCEDRIN
EXTRA STRENGTH PAIN RELIEVER
acetaminophen, aspirin (nsaid), and caffeine tablet, film coated |
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EXCEDRIN 98594008 not registered Live/Pending |
Haleon CH SARL 2024-06-10 |
EXCEDRIN 97425413 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-05-24 |
EXCEDRIN 97210682 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-01-10 |
EXCEDRIN 97210676 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-01-10 |
EXCEDRIN 86434099 4978864 Live/Registered |
GSK CONSUMER HEALTHCARE S.A. 2014-10-24 |
EXCEDRIN 85243455 3985911 Live/Registered |
GSK CONSUMER HEALTHCARE S.A. 2011-02-16 |
EXCEDRIN 74504161 1892912 Dead/Cancelled |
Bristol-Myers Squibb Company 1994-03-23 |
EXCEDRIN 73661685 1472811 Dead/Cancelled |
BRISTOL-MYERS COMPANY 1987-05-18 |
EXCEDRIN 72080162 0696323 Dead/Cancelled |
BRISTOL-MYERS COMPANY 1959-08-25 |